Proteona is pioneering the use of single cell multi-omics to improve clinical outcomes

OUR MISSION

Improve the accuracy of precision medicine

Enable

Enable individual patients to enjoy the benefit of true precision medicine by providing personalized single cell analysis

Empower

Empower clinicians to make informed decisions and select the best treatment option by providing objective, actionable data

Enhance

Enhance clinical trial efficiency and success rate by targeting the right patient population based on proteogenomic signatures

PRODUCTS AND SERVICES

ESCAPE™ single cell multi-omics platform

ESCAPE™ single cell multi-omics platform

From customized antibody panel to library preparation, we assist you in every step of your clinical sample analysis

Bioinformatics

Bioinformatics and AI-assisted single cell data analysis

Obtain clinical insight with the help of our bioinformatics team, in-house reference database, and automated data annotation

Precision-powered clinical trial

Next gen precision-powered clinical trials

With our expertise in designing large single cell studies, performing industry quality analysis, and interpreting clinical data, we help you reach milestones, faster

APPLICATION AREAS

PBMC profiling

Hematology

Profile cancer heterogeneity, analyse tumor microenvironment, and improve targeted therapy for multiple myeloma and other blood cancers

Whole tumor analysis

Solid tumor

Understand drug response and relapse mechanisms. Measure tumor cells, TILs, and support cells in the same assay

Cell therapy characterization

Cell therapy

The ultimate quality control. Measure production consistency, compare manufacturing methods, and evaluate clinical outcome

Find out more about the applications of single cell multi-omics

NEWS

Events

Biomedical business opportunities: Singapore to Germany
  • 11 December 2020
Germany Market opportunities for biomedical companies: SWITCH 2020

Proteona launches Single Cell Multi-Omics Grant for Multiple Myeloma
  • 30 November 2020
Single Cell Multi-Omics Grant for Multiple Myeloma|Proteona

Proteona co-founder presented AI methods for blood cancer precision medicine and personalized treatment
  • 11 November 2020
Using AI for oncology precision medicine
See all Events

Press releases

Proteona among the ten winners of Falling Wall Breakthrough of the Year 2020, Science Start-up
  • 06 November 2020
Proteona among winners of Falling Wall Breakthrough of the Year 2020

Proteona Appointed as a Certified Service Provider by 10x Genomics
  • 06 Auguest 2020
Proteona provide services for data analysis, single cell gene expression with cell surface protein, and single cell gene expression

Proteona featured as a Spinoff Prize “one to watch” by Nature Research and Merck.
  • 30 June 2020
One to watch 2020, the Spinoff Prize
See all Press Releases

TEAM

Andreas Schmidt

Andreas Schmidt

Chief Executive Officer

Jonathan Scolnick

Jonathan Scolnick

Scientific Co-founder

Shawn Hoon

Shawn Hoon

Scientific Co-founder

Charles Goldstein

Charles Goldstein

Advisory Board

Gene Yeo

Gene Yeo

Advisory Board, Scientific Co-founder

Our partners
A*STAR ILO SMART AISG RESTORE LifeTime EIT Health

Contact Information

Proteona Pte. Ltd.
2 Jurong East Street 21 #04-20
Singapore 609601

Proteona GmbH
Cologne, Germany

info@proteona.com

Connect with us on LinkedIn
World map